Screening Biomarkers

This version of the course is no longer available.
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Cardiac Biomarkers (retired 12/6/2013). Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Cardiac Biomarkers (retired 12/6/2013) (online CE course)
Screening Biomarkers

Previously, screening for cardiovascular disease (CVD) focused on hyperlipidemia, obesity, and hypertension. However, approximately one half of AMIs occur in healthy men and women with normal or only slightly elevated plasma lipids. With new insights into cardiac disease and the ACS, novel biomarkers such as inflammatory markers, hormones, and other biomolecules indicating myocardial stress are required. Some new screening markers are in use today and many more are in study and evaluation for future use.

New screening markers for CVD and ACS are:

  • Highly Sensitive C-Reactive Protein (hs-CRP)
  • Homocysteine
  • Ischemial Modified Albumin (IMA)
  • Myeloperoxidase (MPO)